Published in J Natl Cancer Inst on February 21, 2001
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol (2011) 5.59
Human papillomavirus and cervical cancer. Clin Microbiol Rev (2003) 3.90
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol (2009) 2.74
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect (2006) 2.21
Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis (2003) 2.06
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer (2003) 1.90
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev (2009) 1.70
Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol (2010) 1.70
Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res (2009) 1.67
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer (2009) 1.65
Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst (2001) 1.65
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol (2012) 1.60
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev (2008) 1.53
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med (2009) 1.48
comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol (2005) 1.44
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis (2009) 1.35
Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer (2003) 1.30
Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol (2006) 1.24
Making sense of information about HPV in cervical screening: a qualitative study. Br J Cancer (2005) 1.24
HPV testing for clarifying borderline cervical smear results. BMJ (2001) 1.18
European consensus on cancer screening should be applied urgently by health ministers. BMJ (2001) 1.17
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol (2002) 1.14
Cervical cancer prevention--cervical screening: science in evolution. Obstet Gynecol Clin North Am (2007) 1.07
Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn (2005) 1.07
Correlates of IL-10 and IL-12 concentrations in cervical secretions. J Clin Immunol (2003) 1.06
Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol (2005) 1.06
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J Clin Microbiol (2003) 1.05
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J Clin Microbiol (2012) 1.05
Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev (2010) 1.05
Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol (2007) 1.04
Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay. J Clin Microbiol (2008) 1.04
Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. J Clin Microbiol (2011) 1.02
Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix. Br J Cancer (2006) 1.01
Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay. PLoS One (2013) 1.00
Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol (2003) 1.00
Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Prev Med (2013) 0.98
Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer (2003) 0.96
Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol (2009) 0.95
Factors affecting the detection rate of human papillomavirus. Ann Fam Med (2004) 0.93
New insights into cervical cancer screening. J Gynecol Oncol (2012) 0.92
A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens. J Mol Diagn (2007) 0.92
Treatment of the patients with abnormal cervical cytology: a "see-and-treat" versus three-step strategy. J Gynecol Oncol (2009) 0.91
Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection. J Clin Microbiol (2010) 0.91
Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infect Agent Cancer (2008) 0.89
The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol (2005) 0.89
Use of the ThinPrep Imaging System does not alter the frequency of interpreting Papanicolaou tests as atypical squamous cells of undetermined significance. Cytojournal (2008) 0.88
Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PLoS One (2011) 0.87
Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry. PLoS One (2014) 0.87
The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstet Gynecol (2011) 0.87
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Br J Cancer (2003) 0.86
Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China. J Mol Diagn (2010) 0.84
Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening. J Mol Diagn (2002) 0.84
Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial. Health Psychol (2013) 0.84
Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am J Pathol (2002) 0.83
Cancer of the Uterine Cervix. BMC Womens Health (2004) 0.83
[Precancerous lesions of the cervix. Biomarkers in cytological diagnosis]. Pathologe (2011) 0.83
Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J Mol Diagn (2004) 0.82
The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol (2011) 0.82
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix. J Clin Microbiol (2010) 0.82
Effect of glacial acetic acid treatment of liquid-based cytology collections on performance of Cervista HPV HR for detection of high-risk human papillomavirus. J Clin Microbiol (2012) 0.82
Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecol Oncol (2010) 0.82
HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade. PLoS One (2014) 0.81
Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions. Am J Epidemiol (2009) 0.81
Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study. Med Decis Making (2011) 0.81
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections. J Infect Dis (2009) 0.81
Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (cin) 1 and 3. Cancer Inform (2007) 0.80
HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway. Cancer Med (2013) 0.80
Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus. Infect Dis Obstet Gynecol (2011) 0.79
Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping. Cancer Med (2012) 0.79
Outcome of "Atypical Squamous Cells" in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure. Korean J Pathol (2012) 0.79
HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice. Ecancermedicalscience (2012) 0.79
Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis (2012) 0.79
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Cancer Causes Control (2015) 0.79
Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis (2005) 0.79
Human papillomavirus infections in primary care. Clin Med Res (2007) 0.78
Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance. Obstet Gynecol Sci (2015) 0.78
Scientific issues related to the cytology proficiency testing regulations. Cytojournal (2006) 0.78
Detection of human Papillomavirus 18 in cervical cancer samples using PCR-ELISA (DIAPOPS). Iran J Microbiol (2011) 0.78
No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women. Cancer Prev Res (Phila) (2010) 0.77
[Precancerous lesions of the uterine cervix: morphology and molecular pathology]. Pathologe (2011) 0.77
Effect of ThinPrep preparation on human papillomavirus detection and genotyping in rectal samples by PCR. J Clin Microbiol (2008) 0.77
Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program. Br J Cancer (2016) 0.77
[Molecular pathogenesis of cervical cancer and its first steps]. Pathologe (2005) 0.77
Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer (2002) 0.76
Human Papillomavirus Laboratory Testing: the Changing Paradigm. Clin Microbiol Rev (2016) 0.76
Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection. Int J Clin Exp Pathol (2015) 0.75
Prevention of human papillomavirus-related malignancies of the female genital tract. Infect Dis Obstet Gynecol (2012) 0.75
Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions. Med Sci Monit (2015) 0.75
Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia. PLoS One (2015) 0.75
3q26 amplification is an effective negative triage test for LSIL: a historical prospective study. PLoS One (2012) 0.75
Re: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst (2001) 0.75
Cervicoscopy and Microcolposcopy in the Evaluation of Squamo Columnar Junction and Cervical Canal in LSIL Patients with Inadequate or Negative Colposcopy. Int J Biomed Sci (2013) 0.75
Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA (2001) 5.96
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21
Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol (1999) 1.91
Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst (2001) 1.86
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev (2001) 1.77
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci U S A (1987) 1.71
Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests. J Natl Cancer Inst (1998) 1.68
Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature (1983) 1.65
Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol (2001) 1.59
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer (2003) 1.55
Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica. Cancer (1998) 1.54
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer (2001) 1.52
Prevalence and correlates of harassment among US women physicians. Arch Intern Med (1998) 1.43
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Br J Cancer (2004) 1.40
The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis (1988) 1.38
Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures. J Immunol Methods (1999) 1.34
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev (1998) 1.16
Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies. Cancer Res (1993) 1.15
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis (2001) 1.14
Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward. Clin Diagn Lab Immunol (1998) 1.14
Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res (1995) 1.11
Geographic distribution of HTLV-I and identification of a new high-risk population. Int J Cancer (1988) 1.09
Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis (1991) 1.08
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev (1996) 1.08
Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev (2000) 1.05
Development of an assay for aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes. Cancer Res (1976) 1.05
Simple bone cysts: factors of age dependency. Radiology (1977) 1.04
An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States. Am J Obstet Gynecol (1977) 1.03
Epidemiologic determinants of vaginal pH. Am J Obstet Gynecol (1999) 1.02
Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software. J Clin Microbiol (2008) 0.99
Dysplastic naevi and cutaneous melanoma risk. Lancet (1983) 0.99
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis (1999) 0.98
Cervicography screening for cervical cancer among 8460 women in a high-risk population. Am J Obstet Gynecol (1999) 0.96
Chromosome rearrangements in fumigant appliers: possible relationship to non-Hodgkin's lymphoma risk. Cancer Epidemiol Biomarkers Prev (1993) 0.94
A case-control study of endogenous hormones and cervical cancer. Br J Cancer (2004) 0.93
Herbicides and adjuvants: an evolving view. Toxicol Ind Health (1999) 0.93
Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med (1986) 0.93
A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica. Sex Transm Infect (2003) 0.92
Interindividual and intraindividual variations in aryl hydrocarbon hydroxylase in monocytes from monozygotic and dizygotic twins. Cancer Res (1977) 0.91
Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial. Am J Obstet Gynecol (2000) 0.87
A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix. Nutr Cancer (1998) 0.87
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer. Tissue Antigens (2005) 0.87
Diagnostic certainty in pancreatic cancer. J Clin Epidemiol (1996) 0.86
Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst (2001) 0.86
Improved radioimmunoassay technique for measuring serum thymopoietin. Clin Chim Acta (1980) 0.84
Childhood exposure to magnetic fields: residential area measurements compared to personal dosimetry. Epidemiology (1996) 0.84
Differential effects of dietary beta-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin. Carcinogenesis (1993) 0.83
p53 polymorphism and risk of cervical cancer. Nature (1998) 0.83
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol Biomarkers Prev (1995) 0.83
A study of lobular carcinoma of the breast based on the Third National Cancer Survey in The United States of America. Tumori (1979) 0.83
Radiometric assay of red cell and plasma cholinesterase in pesticide appliers from Minnesota. Toxicol Appl Pharmacol (1993) 0.82
"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol (1999) 0.80
The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysis. BJOG (2014) 0.79
Cervicography for triage of women with mildly abnormal cervical cytology results. Am J Obstet Gynecol (2001) 0.79
Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears. Cancer (2000) 0.79
Laboratory and epidemiologic studies of fecapentaenes. Mutat Res (1991) 0.78
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 0.78
Plasma cytokine levels and human papillomavirus infection at the cervix in rural Nigerian women. Cytokine (2013) 0.78
A prospective study of biopsy-confirmed cervical intraepithelial neoplasia grade 1: colposcopic, cytological, and virological risk factors for progression. J Low Genit Tract Dis (1999) 0.78
Serum antibodies to HPV 16 virus-like particles are not associated with penile cancer in Chinese males. Viral Immunol (1996) 0.77
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle. Br J Cancer (2006) 0.77
Sex hormones in lesbian and heterosexual women. Horm Behav (1987) 0.76
Research priorities in large bowel cancer prevention. Semin Oncol (1990) 0.76
Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica. Cancer Epidemiol Biomarkers Prev (1999) 0.76
An epidemiologic perspective on biomarkers. J Intern Med (1993) 0.76
Re: Emerging technologies and cervical cancer. J Natl Cancer Inst (2000) 0.75
Cervical HPV DNA detection as a predictor of a recurrent SIL diagnosis among untreated women. J Low Genit Tract Dis (2001) 0.75
Induced movement based on subtraction of motion from the inducing object. J Exp Psychol Hum Percept Perform (1980) 0.75
Regarding mutagenic mucus in the cervix of smokers. J Natl Cancer Inst (1987) 0.75
A critical evaluation of the scientific basis of the MAK Commission's new general threshold limit values for dust. Int Arch Occup Environ Health (2001) 0.75
HPV testing and visual inspection for cervical cancer screening in resource-poor regions. Int J Gynaecol Obstet (2003) 0.75
Dietary retinoic acid inhibits mouse skin carcinogenesis irrespective of age at initiation. Nutr Cancer (1996) 0.75
Behind bars. Am Pharm (1979) 0.75
Chromosome aberrations in lymphocytes--biomonitors of radiation exposure. Prog Clin Biol Res (1991) 0.75